Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Medtronic
Queensland Health
Teva
Cerilliant
Argus Health
Chubb
McKinsey
Harvard Business School

Generated: April 25, 2018

DrugPatentWatch Database Preview

AMIKIN Drug Profile

« Back to Dashboard

Which patents cover Amikin, and when can generic versions of Amikin launch?

Amikin is a drug marketed by Apothecon and is included in four NDAs.

The generic ingredient in AMIKIN is amikacin sulfate. There are fifteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the amikacin sulfate profile page.
Drug patent expirations by year for AMIKIN
Medical Subject Heading (MeSH) Categories for AMIKIN
Synonyms for AMIKIN
(2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-(3-amino-3-deoxy-alpha-D-glucopyranosyloxy)-4-(6-amino-6-deoxy-alpha-D-glucopyranosyloxy)-3-hydroxycyclohexyl]-2-hydroxybutanamide
(2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-[(2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide
(2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-4-[(2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-trihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-cyclohexyl]-
(2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-{[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4-{[(2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-3-hydroxycyclohexyl]-2-hydroxybutanamide
(2S)-4-amino-N-{(1R,2S,3S,4R,5S)-5-amino-2-[(3-amino-3-deoxy-alpha-D-glucopyranosyl)oxy]-4-[(6-amino-6-deoxy-alpha-D-glucopyranosyl)oxy]-3-hydroxycyclohexyl}-2-hydroxybutanamide
(2s)-N-[(1r,2s,3s,4r,5s)-4-[(2r,3r,4s,5s,6r)-6-(Aminomethyl)-3,4,5-Tris(Oxidanyl)oxan-2-Yl]oxy-5-Azanyl-2-[(2s,3r,4s,5s,6r)-4-Azanyl-6-(Hydroxymethyl)-3,5-Bis(Oxidanyl)oxan-2-Yl]oxy-3-Oxidanyl-Cyclohexyl]-4-Azanyl-2-Oxidanyl-
(S)-O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1-4))-N1-(4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-D-streptamine
1-N-(L-(-)-4-Amino-2-hydroxybutyryl)kanamycin A
1-N-(L(-)-gamma-Amino-alpha-hydroxybutyryl)kanamycin A
1079316-47-4
108914-65-4
110660-81-6
110660-83-8
111319-93-8
37517-28-5
38859-32-4
517A285
6462-EP1441224A2
6462-EP2292612A2
6462-EP2295402A2
6462-EP2301544A1
84319SGC3C
AB00513828
AB00513828_06
AC1L1YE8
AC1Q5JTM
AKN
AKOS005383276
Amicacin
Amiglyde-V
Amiglyde-V (TN)
Amikacillin
amikacin
Amikacin (USP)
Amikacin (USP/INN)
Amikacin [USAN:BAN:INN]
Amikacin [USP:INN:BAN]
Amikacin & Tumor Necrosis Factor
Amikacin Base
Amikacin Dihydrate
Amikacin Inhalation Solution
AMIKACIN SULFATE
Amikacin, Antibiotic for Culture Media Use Only
AMIKACIN, USP
Amikacina
Amikacina [INN-Spanish]
amikacine
Amikacine [INN-French]
Amikacinum
Amikacinum [INN-Latin]
Amikavet
Amikin (Disulfate)
Amikin(Disulfate)
Amiklin
Amikozit
Amukin
Antibiotic BB-K 8
ANTIBIOTIC BB-K8
API0001444
Arikace
AX8113844
BAY 41-6551
BAY41-6551
BAY416651
BB-K 8
BB-K8
BPBio1_000671
Briclin
BSPBio_000609
C06820
C22H43N5O13
CA009758
CAS-37517-28-5
CHEBI:2637
CHEMBL177
CS-2712
D-Streptamine, O-3-amino-3-deoxy-.alpha.-D-glucopyranosyl-(1->6)-O-[6-amino-6-deoxy-.alpha.-D-glucopyranosyl-(1->4)]-N1-[(2S)-4-amino-2-hydroxy-1-oxobutyl]-2-deoxy-
D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1->6)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1->4))-N(sup 1)-(4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-, (S)-
D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1-4))-N(sup 1)-(4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-, (S)-
D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1-4))-N1-(4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-, (S)-
D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1,4))-N(sup 1)-(4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-, (S)-
D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1.fwdarw.6)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1.fwdarw.4))-N1-((2S)-4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-
D02543
D0Y3MO
DB00479
DR003325
DSSTox_CID_2586
DSSTox_GSID_22586
DSSTox_RID_76645
DTXSID3022586
EINECS 253-538-5
H978
HSDB 3583
HY-B0509A
Kaminax
LKCWBDHBTVXHDL-RMDFUYIESA-N
LS-146896
Lukadin
MAT2501
MCULE-6148260173
MFCD00883675
MFCD11045969
Mikavir
MolPort-000-761-900
N1-[(S)-4-Amino-2-hydroxybutyryl]kanamycin A
NCGC00093350-02
NCGC00093350-03
NCGC00093350-05
nktr-061
NSC 177001
NSC177001
O-3-Amino-3-deoxy-.alpha.-D-glucopyranosyl-(1->6)-O-[6-amino-6-deoxy-.alpha.-D-glucopyranosyl-(1->4)]-1-(4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-D-streptamine
O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1->4)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1->6))-N(3)-(4-amino-L-2-hydroxybutyryl)-2-deoxy-L-streptamine
O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1-6))-N(sup 3)-(4-amino-L-2-hydroxybutyryl)-2-deoxy-L-streptamine
Pierami
Potentox
Prestwick3_000395
SCHEMBL2985
STK039706
Tox21_111201
Tox21_111201_1
UNII-84319SGC3C
W-106531
ZINC8214483

US Patents and Regulatory Information for AMIKIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apothecon AMIKIN amikacin sulfate INJECTABLE;INJECTION 062311-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Apothecon AMIKIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER amikacin sulfate INJECTABLE;INJECTION 050618-002 Nov 30, 1987 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Apothecon AMIKIN amikacin sulfate INJECTABLE;INJECTION 062311-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Apothecon AMIKIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER amikacin sulfate INJECTABLE;INJECTION 050618-001 Nov 30, 1987 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Chubb
Harvard Business School
Queensland Health
Mallinckrodt
Citi
Healthtrust
Cerilliant
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.